Can Fite Biopharma Ltd
CANF4.160USD
+0.100+2.35%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
5.50M시가총액
손실P/E TTM
자세한 내용은 Can Fite Biopharma Ltd 회사
Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Can Fite Biopharma Ltd 정보
종목 코드 CANF
회사 이름Can Fite Biopharma Ltd
상장일Sep 22, 2005
CEOFishman (Pnina)
직원 수5
유형Depository Receipt
회계 연도 종료Sep 22
주소10 Bareket Street, Kiryat Matalon
도시PETAH TIKVA
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가Israel
우편 번호49170
전화97239241114
웹사이트https://www.canfite.com/
종목 코드 CANF
상장일Sep 22, 2005
CEOFishman (Pnina)
Can Fite Biopharma Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
Mr. Yoseph Borenstein
Mr. Yoseph Borenstein
Director
Director
--
--
Mr. Yaacov Goldman
Mr. Yaacov Goldman
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Pnina Fishman, Ph.D.
Dr. Pnina Fishman, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Ilan Cohen
Dr. Ilan Cohen
Chairman of the Board
Chairman of the Board
--
--
Mr. Motti Farbstein
Mr. Motti Farbstein
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. Abraham Sartani, M.D.
Dr. Abraham Sartani, M.D.
Independent Director
Independent Director
--
--
Mr. Guy Regev
Mr. Guy Regev
Independent Director
Independent Director
--
--
Dr. Sari Fishman, Ph.D.
Dr. Sari Fishman, Ph.D.
Vice President - Business Development
Vice President - Business Development
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Tue, Jan 6
마지막 업데이트: Tue, Jan 6
주주
주주 유형
주주
주주
비율
Sabby Management, LLC
5.37%
Rhumbline Advisers Ltd. Partnership
0.22%
Abalone Asset Management Ltd.
0.09%
UBS Financial Services, Inc.
0.08%
BNP Paribas Securities Corp. North America
0.06%
기타
94.17%
주주
주주
비율
Sabby Management, LLC
5.37%
Rhumbline Advisers Ltd. Partnership
0.22%
Abalone Asset Management Ltd.
0.09%
UBS Financial Services, Inc.
0.08%
BNP Paribas Securities Corp. North America
0.06%
기타
94.17%
주주 유형
주주
비율
Investment Advisor/Hedge Fund
5.37%
Investment Advisor
0.51%
Research Firm
0.12%
Hedge Fund
0.04%
기타
93.96%
기관 주식 보유
마지막 업데이트: Mon, Dec 8
마지막 업데이트: Mon, Dec 8
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
30
1.56M
6.39%
--
2025Q3
33
1.56M
9.88%
+633.60K
2025Q2
31
928.79K
6.69%
+773.65K
2025Q1
30
155.14K
8.36%
-710.63K
2024Q4
28
138.24K
8.71%
-639.91K
2024Q3
26
778.14K
10.55%
+126.51K
2024Q2
26
651.74K
10.05%
+134.05K
2024Q1
24
517.69K
5.29%
+253.94K
2023Q4
29
283.94K
2.08%
+216.17K
2023Q3
28
67.77K
12.19%
+13.03K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Sabby Management, LLC
70.30K
5.37%
+31.32K
+80.32%
Sep 30, 2025
Rhumbline Advisers Ltd. Partnership
2.90K
0.22%
+18.00
+0.63%
Sep 30, 2025
Abalone Asset Management Ltd.
1.19K
0.09%
-809.00
-40.45%
Jun 30, 2024
UBS Financial Services, Inc.
65.00
0.01%
-211.00
-76.45%
Sep 30, 2025
BNP Paribas Securities Corp. North America
829.00
0.06%
-50.00
-5.69%
Sep 30, 2025
Bogart Wealth, LLC
752.00
0.06%
+752.00
--
Sep 30, 2025
Morgan Stanley & Co. LLC
626.00
0.05%
+130.00
+26.21%
Sep 30, 2025
CAPTRUST Financial Advisors
569.00
0.04%
--
--
Sep 30, 2025
Two Sigma Investments, LP
532.00
0.04%
-271.00
-33.75%
Sep 30, 2025
MainStreet Advisors
150.00
0.01%
--
--
Sep 30, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Dec 23, 2025
Merger
20→1
Dec 23, 2025
Merger
20→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
날짜
배당락일
유형
비율
Dec 23, 2025
Merger
20→1
Dec 23, 2025
Merger
20→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
Jan 03, 2023
Merger
10→1
